Cargando…
Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
Early treatment may prevent or delay the onset of type 2 diabetes mellitus (T2DM) in individuals who are at high risk. Lifestyle interventions and the hypoglycemic drug metformin have been shown to reduce T2DM incidence. The effectiveness of such interventions may be enhanced by targeting environmen...
Autores principales: | Palacios, Talia, Vitetta, Luis, Coulson, Samantha, Madigan, Claire D., Lam, Yan Y., Manuel, Rachel, Briskey, David, Hendy, Chelsea, Kim, Ji-Nu, Ishoey, Thomas, Soto-Giron, Maria J., Schott, Eric M., Toledo, Gerardo, Caterson, Ian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400852/ https://www.ncbi.nlm.nih.gov/pubmed/32660025 http://dx.doi.org/10.3390/nu12072041 |
Ejemplares similares
-
The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial
por: Palacios, Talia, et al.
Publicado: (2017) -
The Edible Plant Microbiome represents a diverse genetic reservoir with functional potential in the human host
por: Soto-Giron, Maria J., et al.
Publicado: (2021) -
Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders
por: Lam, Yan Y., et al.
Publicado: (2017) -
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?
por: Evans, Marc, et al.
Publicado: (2019) -
Glycaemia and critical care outcomes
por: Cecconi, M, et al.
Publicado: (2014)